Visual Performance of New Apodized Diffractive Multifocal IOL With Addition of Plus Three

Sponsor
University of Sao Paulo (Other)
Overall Status
Completed
CT.gov ID
NCT01027533
Collaborator
(none)
32
1

Study Details

Study Description

Brief Summary

The purpose of the study is to determine whether implantation of a multifocal IOL with a modified addition at lens plane(Restor +3) results in better intermediate visual acuity with similar performance at distance and near compared to other multifocal IOL with similar design but with higher addition at lens plane. Patient's contrast sensitivity of vision and best reading distance following Restor +3 implantation were also assessed.

Study hypothesis: the implantation of an intraocular lens (IOL) with a modified addition at lens plane (restor +3, Alcon Laboratories,Inc) results in better intermediate visual acuity with similar distance and near visual acuity after cataract surgery.

Condition or Disease Intervention/Treatment Phase
  • Other: Implantation of a multifocal Intraocular lens

Detailed Description

Patients with bilateral visually significant cataract with corneal astigmatism lower than 1.0D (diopters) will be eligible for inclusion in the study. Exclusion criteria will be any ocular diseases, such as corneal opacities or irregularity, dry eye, amblyopia, anisometropia, glaucoma, retinal abnormalities, surgical complications, IOL tilt, IOL decentration greater than 0.4 mm (estimated by retroillumination), or incomplete follow-up.

Patients will be examined before surgery and at 1, 7, 30, 90 days and 3and 6 months after surgery.

Study Design

Study Type:
Observational
Anticipated Enrollment :
32 participants
Time Perspective:
Prospective
Study Start Date :
Dec 1, 2009
Actual Primary Completion Date :
Dec 1, 2009
Actual Study Completion Date :
Dec 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Restor +3

patients will be implanted bilaterally with Restor + 3

Other: Implantation of a multifocal Intraocular lens
Bilateral implantation of a multifocal IOl
Other Names:
  • Restor + 3 SN6AD1
  • Restor + 4 SN6AD3
  • restor +4

    Patients will be implanted bilaterally with Restor +4

    Other: Implantation of a multifocal Intraocular lens
    Bilateral implantation of a multifocal IOl
    Other Names:
  • Restor + 3 SN6AD1
  • Restor + 4 SN6AD3
  • Outcome Measures

    Primary Outcome Measures

    1. distance,intermediate and near visual acuity [1, 3 and 6 months]

    Secondary Outcome Measures

    1. reading speed and contrast sensitivity [6 months]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    40 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • •Patients with bilateral visually significant cataract with corneal astigmatism lower than 1.0D (diopters)
    Exclusion Criteria:
    • Ocular diseases, such as corneal opacities or irregularity, dry eye amblyopia, anisometropia, glaucoma, retinal abnormalities

    • Surgical complications

    • Intraocular lens (IOL) tilt, IOL decentration greater than 0.4 mm (estimated by retroillumination)

    • Incomplete follow-up.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of São Paulo São Paulo SP Brazil 054000

    Sponsors and Collaborators

    • University of Sao Paulo

    Investigators

    • Principal Investigator: Marcony Santhiago, MD, University of São Paulo

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT01027533
    Other Study ID Numbers:
    • MRS.1703
    First Posted:
    Dec 8, 2009
    Last Update Posted:
    Jul 2, 2010
    Last Verified:
    Mar 1, 2009

    Study Results

    No Results Posted as of Jul 2, 2010